Goldfeld A E, Delgado J C, Thim S, Bozon M V, Uglialoro A M, Turbay D, Cohen C, Yunis E J
Division of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
JAMA. 1998 Jan 21;279(3):226-8. doi: 10.1001/jama.279.3.226.
Although tuberculosis (TB) is the leading worldwide cause of death due to an infectious disease, the extent to which progressive clinical disease is associated with genetic host factors remains undefined.
To determine the distribution of HLA antigens and the frequency of 2 alleles of the tumor necrosis factor alpha (TNF-alpha) gene in unrelated individuals with clinical TB (cases) compared with individuals with no history of clinical TB (controls) in a population with a high prevalence of TB exposure.
A 2-stage, case-control molecular typing study conducted in 1995-1996.
Three district hospitals in Svay Rieng Province in rural Cambodia.
A total of 78 patients with clinical TB and 49 controls were included in the first stage and 48 patients with TB and 39 controls from the same area and socioeconomic status were included in the second stage.
Presence of HLA class I and class II alleles determined by sequence-specific oligonucleotide probe hybridization and presence of 2 TNF-alpha alleles determined by restriction fragment length polymorphism analysis.
In the first stage, 7 DQB10503 alleles were detected among 156 alleles derived from patients with TB, whereas no DQB10503 alleles were found among the 98 alleles derived from controls (P=.04). There was no detectable difference in the distribution of the 2 TNF-alpha alleles in patients with TB compared with controls. In the second stage, we tested for the presence of a single variable, the DQB10503 allele, and found 9 DQB10503 alleles among 96 alleles derived from patients with TB and no DQB1*0503 alleles among 78 alleles in controls (P=.005).
The HLA-DQB1*0503 allele is significantly associated with susceptibility to TB in Cambodian patients and, to our knowledge, is the first identified gene associated with development of clinical TB.
虽然结核病是全球因传染病导致死亡的首要原因,但进展性临床疾病与宿主遗传因素的关联程度仍不明确。
在结核病暴露率高的人群中,确定临床结核病患者(病例组)与无临床结核病病史者(对照组)中HLA抗原的分布情况以及肿瘤坏死因子α(TNF-α)基因两个等位基因的频率。
1995 - 1996年进行的两阶段病例对照分子分型研究。
柬埔寨农村柴桢省的三家地区医院。
第一阶段纳入78例临床结核病患者和49例对照,第二阶段纳入来自同一地区且社会经济地位相同的48例结核病患者和39例对照。
通过序列特异性寡核苷酸探针杂交确定HLAⅠ类和Ⅱ类等位基因的存在情况,通过限制性片段长度多态性分析确定两个TNF-α等位基因的存在情况。
在第一阶段,从结核病患者的156个等位基因中检测到7个DQB10503等位基因,而在对照组的98个等位基因中未发现DQB10503等位基因(P = 0.04)。结核病患者与对照组相比,两个TNF-α等位基因的分布没有可检测到的差异。在第二阶段,我们检测了单一变量DQB10503等位基因的存在情况,在结核病患者的96个等位基因中发现9个DQB10503等位基因,而对照组的78个等位基因中未发现DQB1*0503等位基因(P = 0.005)。
HLA - DQB1*0503等位基因与柬埔寨患者对结核病的易感性显著相关,据我们所知,这是首个被鉴定出与临床结核病发生相关的基因。